A nationwide study on reproductive function, ovarian reserve, and risk of premature menopause in female survivors of childhood cancer: design and methodological challenges.

Abstract:

BACKGROUND:Advances in childhood cancer treatment over the past decades have significantly improved survival, resulting in a rapidly growing group of survivors. However, both chemo- and radiotherapy may adversely affect reproductive function. This paper describes the design and encountered methodological challenges of a nationwide study in the Netherlands investigating the effects of treatment on reproductive function, ovarian reserve, premature menopause and pregnancy outcomes in female childhood cancer survivors (CCS), the DCOG LATER-VEVO study. METHODS:The study is a retrospective cohort study consisting of two parts: a questionnaire assessing medical, menstrual, and obstetric history, and a clinical assessment evaluating ovarian and uterine function by hormonal analyses and transvaginal ultrasound measurements. The eligible study population consists of adult female 5-year survivors of childhood cancer treated in the Netherlands, whereas the control group consists of age-matched sisters of the participating CCS. To date, study invitations have been sent to 1611 CCS and 429 sister controls, of which 1215 (75%) and 333 (78%) have responded so far. Of these responders, the majority consented to participate in both parts of the study (53% vs. 65% for CCS and sister controls respectively). Several challenges were encountered involving the study population: dealing with bias due to the differences in characteristics of several types of (non-) participants and finding an adequately sized and well-matched control group. Moreover, the challenges related to the data collection process included: differences in response rates between web-based and paper-based questionnaires, validity of self-reported outcomes, interpretation of clinical measurements of women using hormonal contraceptives, and inter- and intra-observer variation of the ultrasound measurements. DISCUSSION:The DCOG LATER-VEVO study will provide valuable information about the reproductive potential of paediatric cancer patients as well as long-term survivors of childhood cancer. Other investigators planning to conduct large cohort studies on late effects may encounter similar challenges as those encountered during this study. The solutions to these challenges described in this paper may be useful to these investigators. TRIAL REGISTRATION:NTR2922; http://www.trialregister.nl/trialreg/admin/rctview.asp?TC=2922

journal_name

BMC Cancer

journal_title

BMC cancer

authors

Overbeek A,van den Berg MH,Kremer LC,van den Heuvel-Eibrink MM,Tissing WJ,Loonen JJ,Versluys B,Bresters D,Kaspers GJ,Lambalk CB,van Leeuwen FE,van Dulmen-den Broeder E,DCOG LATER-VEVO study group.

doi

10.1186/1471-2407-12-363

subject

Has Abstract

pub_date

2012-08-23 00:00:00

pages

363

issn

1471-2407

pii

1471-2407-12-363

journal_volume

12

pub_type

杂志文章
  • Chemotherapy and radiation therapy elicits tumor specific T cell responses in a breast cancer patient.

    abstract:BACKGROUND:Experimental evidence and clinical studies in breast cancer suggest that some anti-tumor therapy regimens generate stimulation of the immune system that accounts for tumor clinical responses, however, demonstration of the immunostimulatory power of these therapies on cancer patients continues to be a formida...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-016-2625-2

    authors: Bernal-Estévez D,Sánchez R,Tejada RE,Parra-López C

    更新日期:2016-08-03 00:00:00

  • MiR-200c and HuR in ovarian cancer.

    abstract:BACKGROUND:MicroRNAs in solid malignancies can behave as predictors of either good or poor outcome. This is the case with members of the miR-200 family, which are the primary regulators of the epithelial to mesenchymal transition and have been reported to act as both oncogenes and tumor suppressors. This study assessed...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-72

    authors: Prislei S,Martinelli E,Mariani M,Raspaglio G,Sieber S,Ferrandina G,Shahabi S,Scambia G,Ferlini C

    更新日期:2013-02-08 00:00:00

  • Cancer incidence and mortality in Serbia 1999-2009.

    abstract:BACKGROUND:Despite the increase in cancer incidence in the last years in Serbia, no nation-wide, population-based cancer epidemiology data have been reported. In this study cancer incidence and mortality rates for Serbia are presented using nation-wide data from two population-based cancer registries. These rates are a...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-13-18

    authors: Mihajlović J,Pechlivanoglou P,Miladinov-Mikov M,Zivković S,Postma MJ

    更新日期:2013-01-15 00:00:00

  • GENESIS: a French national resource to study the missing heritability of breast cancer.

    abstract:BACKGROUND:Less than 20% of familial breast cancer patients who undergo genetic testing for BRCA1 and BRCA2 carry a pathogenic mutation in one of these two genes. The GENESIS (GENE SISter) study was designed to identify new breast cancer susceptibility genes in women attending cancer genetics clinics and with no BRCA1/...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-2028-9

    authors: Sinilnikova OM,Dondon MG,Eon-Marchais S,Damiola F,Barjhoux L,Marcou M,Verny-Pierre C,Sornin V,Toulemonde L,Beauvallet J,Le Gal D,Mebirouk N,Belotti M,Caron O,Gauthier-Villars M,Coupier I,Buecher B,Lortholary A,Dugast

    更新日期:2016-01-12 00:00:00

  • RAM score is an effective predictor for early mortality and recurrence after hepatectomy for hepatocellular carcinoma.

    abstract:BACKGROUND:Liver resection had been regarded as a standard treatment for primary hepatocellular carcinoma (HCC). However, early mortality and recurrence after surgery were still of major concern. RAM (Risk Assessment for early Mortality) scoring system is a newly developed tool for assessing early mortality after hepat...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3748-9

    authors: Hsu HY,Yu MC,Lee CW,Tsai HI,Sung CM,Chen CW,Huang SW,Lin CY,Jeng WJ,Lee WC,Chen MF

    更新日期:2017-11-09 00:00:00

  • Gastric Helicobacter pylori infection associates with an increased risk of colorectal polyps in African Americans.

    abstract:BACKGROUND:Gastric Helicobacter pylori (H. pylori) infection and colorectal polyps are more prevalent in African Americans than in the general population. We aimed to investigate whether gastric H. pylori infection is associated with colorectal polyps in African Americans. METHODS:Medical records of African Americans,...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-296

    authors: Brim H,Zahaf M,Laiyemo AO,Nouraie M,Pérez-Pérez GI,Smoot DT,Lee E,Razjouyan H,Ashktorab H

    更新日期:2014-04-28 00:00:00

  • Establishment and identification of a rabbit model of peritoneal carcinomatosis from gastric cancer.

    abstract:BACKGROUND:Gastric cancer peritoneal carcinomatosis is a common clinical problem, but there are no suitable large animal models to study this problem. This study was to establish a stable rabbit peritoneal carcinomatosis model of gastric cancer using VX2 tumor, and analyze the clinico-pathological features. METHODS:VX...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-10-124

    authors: Mei LJ,Yang XJ,Tang L,Hassan AH,Yonemura Y,Li Y

    更新日期:2010-04-01 00:00:00

  • Tumour shrinkage at 6 weeks predicts favorable clinical outcomes in a phase III study of gemcitabine and oxaliplatin with or without erlotinib for advanced biliary tract cancer.

    abstract:BACKGROUND:The aim of this study was to determine whether early tumor shrinkage (ETS) at 6 weeks after treatment correlates with progression-free survival (PFS) and overall survival (OS) in advanced biliary tract cancer (BTC) patients receiving gemcitabine plus oxaliplatin (GEMOX), with or without erlotinib. METHODS:T...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-015-1552-y

    authors: Kim ST,Jang KT,Lee SJ,Jang HL,Lee J,Park SH,Park YS,Lim HY,Kang WK,Park JO

    更新日期:2015-07-21 00:00:00

  • The -786T>C promoter polymorphism of the NOS3 gene is associated with prostate cancer progression.

    abstract:BACKGROUND:There is no biological or epidemiological data on the association between NOS3 promoter polymorphisms and prostate cancer. The polymorphisms in the promoter region of NOS3 gene may be responsible for variations in the plasma NO, which may promote cancer progression by providing a selective growth advantage t...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-8-273

    authors: Marangoni K,Araújo TG,Neves AF,Goulart LR

    更新日期:2008-09-29 00:00:00

  • Stereotactic body radiotherapy (SBRT) in patients with lung metastases - prognostic factors and long-term survival using patient self-reported outcome (PRO).

    abstract:OBJECTIVES:The present study aims to evaluate long-term side-effects and outcomes and confirm prognostic factors after stereotactic body radiotherapy (SBRT) of pulmonary lesions. This is the first work that combines the investigated data from patient charts and patient-reported outcome (PRO) up to 14 years after therap...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-6635-8

    authors: Kessel KA,Grosser RCE,Kraus KM,Hoffmann H,Oechsner M,Combs SE

    更新日期:2020-05-19 00:00:00

  • The clinical features and treatment modality of esophageal neuroendocrine tumors: a multicenter study in Korea.

    abstract:BACKGROUND:Neuroendocrine tumors (NETs) of the esophagus are extremely rare, and few cases have been reported worldwide. Thus, a comprehensive nationwide study is needed to understand the characteristics of and treatment strategy for esophageal NETs. METHODS:We collected data on esophageal NET patients from 25 hospita...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1186/1471-2407-14-569

    authors: Lee CG,Lim YJ,Park SJ,Jang BI,Choi SR,Kim JK,Kim YT,Cho JY,Yang CH,Chun HJ,Song SY,Neuroendocrine tumor study group.

    更新日期:2014-08-07 00:00:00

  • Circular RNA hsa_circ_0000282 contributes to osteosarcoma cell proliferation by regulating miR-192/XIAP axis.

    abstract:BACKGROUND:Circular RNAs (circRNAs) have emerged as a novel category of non-coding RNA, which exhibit a pivotal effect on regulating gene expression and biological functions, yet how circRNAs function in osteosarcoma (OSA) still demands further investigation. This study aimed at probing into the function of hsa_circ_00...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07515-8

    authors: Li H,He L,Tuo Y,Huang Y,Qian B

    更新日期:2020-10-23 00:00:00

  • Evaluation of treatment response and resistance in metastatic renal cell cancer (mRCC) using integrated 18F-Fluorodeoxyglucose (18F-FDG) positron emission tomography/magnetic resonance imaging (PET/MRI); The REMAP study.

    abstract:BACKGROUND:Tyrosine kinase inhibitors are the first line standard of care for treatment of metastatic renal cell carcinoma (RCC). Accurate response assessment in the setting of antiangiogenic therapies remains suboptimal as standard size-related response criteria do not necessarily accurately reflect clinical benefit, ...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章

    doi:10.1186/s12885-017-3371-9

    authors: Kelly-Morland C,Rudman S,Nathan P,Mallett S,Montana G,Cook G,Goh V

    更新日期:2017-06-02 00:00:00

  • Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.

    abstract:BACKGROUND:Pneumatosis cystoides intestinalis (PCI) is a rare self-limiting condition characterized by air-filled cysts within intestinal walls. Diagnosis should be prudent because it can mimic pneumoperitoneum leading to unnecessary treatment such as surgical exploration. Although various drugs including anti-neoplast...

    journal_title:BMC cancer

    pub_type: 杂志文章,评审

    doi:10.1186/s12885-017-3744-0

    authors: Lee YS,Han JJ,Kim SY,Maeng CH

    更新日期:2017-11-09 00:00:00

  • DECIDER: prospective randomized multicenter phase II trial of low-dose decitabine (DAC) administered alone or in combination with the histone deacetylase inhibitor valproic acid (VPA) and all-trans retinoic acid (ATRA) in patients >60 years with acute mye

    abstract:BACKGROUND:Acute myeloid leukemia (AML) is predominantly a disease of older patients with a poor long-term survival. Approval of decitabine (DAC) in the European Union (EU) in 2012 for the treatment of patients with AML ≥65 years marks the potential for hypomethylating agents in elderly AML. Nevertheless the situation ...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/s12885-015-1432-5

    authors: Grishina O,Schmoor C,Döhner K,Hackanson B,Lubrich B,May AM,Cieslik C,Müller MJ,Lübbert M

    更新日期:2015-05-26 00:00:00

  • First case of AML with rare chromosome translocations: a case report of twins.

    abstract:BACKGROUND:Leukemia is different from solid tumor by harboring genetic rearrangements that predict prognosis and guide treatment strategy. PML-RARA, RUNX1-RUNX1T1, and KMT2A-rearrangement are common genetic rearrangements that drive the development of acute myeloid leukemia (AML). By contrast, rare genetic rearrangemen...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-018-4396-4

    authors: Wang L,Sun Y,Sun Y,Meng L,Xu X

    更新日期:2018-04-23 00:00:00

  • A pilot study of improved psychological distress with art therapy in patients with cancer undergoing chemotherapy.

    abstract:BACKGROUND:Art therapy may improve the physical, mental, and emotional wellbeing of individuals for a variety of purposes. It remains understudied and underutilized in cancer care. We sought to determine the ability of a pilot art therapy program to improve the physical, mental, and emotional well-being of cancer patie...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07380-5

    authors: Elimimian EB,Elson L,Stone E,Butler RS,Doll M,Roshon S,Kondaki C,Padgett A,Nahleh ZA

    更新日期:2020-09-22 00:00:00

  • Perioperative blood transfusion does not affect recurrence-free and overall survivals after curative resection for intrahepatic cholangiocarcinoma: a propensity score matching analysis.

    abstract:BACKGROUND:Whether perioperative blood transfusions (PBTs) adversely influence oncological outcomes for intrahepatic cholangiocarcinoma (ICC) patients after curative resection remains undetermined. METHODS:Of the 605 patients who underwent curative liver resection for ICC between 2000 and 2012, 93 received PBT. We con...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-017-3745-z

    authors: Zhou PY,Tang Z,Liu WR,Tian MX,Jin L,Jiang XF,Wang H,Tao CY,Ding ZB,Peng YF,Qiu SJ,Dai Z,Zhou J,Fan J,Shi YH

    更新日期:2017-11-14 00:00:00

  • Evaluation of the walk-through inflatable colon as a colorectal cancer education tool: results from a pre and post research design.

    abstract:BACKGROUND:Colorectal cancer (CRC) is a disease that can be prevented through early detection. Through the use of effective educational tools, individuals can become better informed about CRC and understand the importance of screening and early detection. The walk through Inflatable Colon is an innovative educational r...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-14-626

    authors: Sanchez JI,Palacios R,Cole A,O'Connell MA

    更新日期:2014-08-28 00:00:00

  • Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

    abstract:BACKGROUND:The effect of current therapies in improving the survival of lung cancer patients remains far from satisfactory. It is consequently desirable to find more appropriate therapeutic opportunities based on informed insights. A molecular pharmacological analysis was undertaken to design an improved chemotherapeut...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-6-174

    authors: Gemma A,Li C,Sugiyama Y,Matsuda K,Seike Y,Kosaihira S,Minegishi Y,Noro R,Nara M,Seike M,Yoshimura A,Shionoya A,Kawakami A,Ogawa N,Uesaka H,Kudoh S

    更新日期:2006-06-30 00:00:00

  • Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases.

    abstract:BACKGROUND:The nucleic acid mutation status in intracranial metastasis is markedly significant clinically. The goal of the current study was to explore whether the tumor-associated mutations can be detected by different next-generation sequencing (NGS) pipelines in paired cerebrospinal fluid (CSF) and plasma samples fr...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-019-5348-3

    authors: Ge M,Zhan Q,Zhang Z,Ji X,Zhou X,Huang R,Liang X

    更新日期:2019-02-12 00:00:00

  • Mesothelioma patient derived tumor xenografts with defined BAP1 mutations that mimic the molecular characteristics of human malignant mesothelioma.

    abstract:BACKGROUND:The development and evaluation of new therapeutic approaches for malignant mesothelioma has been sparse due, in part, to lack of suitable tumor models. METHODS:We established primary mesothelioma cultures from pleural and ascitic fluids of five patients with advanced mesothelioma. Electron microscopy and im...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1362-2

    authors: Kalra N,Zhang J,Thomas A,Xi L,Cheung M,Talarchek J,Burkett S,Tsokos MG,Chen Y,Raffeld M,Miettinen M,Pastan I,Testa JR,Hassan R

    更新日期:2015-05-08 00:00:00

  • Diagnosis delay of breast cancer and its associated factors in Malaysian women.

    abstract:BACKGROUND:Breast cancer is the leading cause of cancer mortality among women in Malaysia. Delayed diagnosis is preventable and has major effects on patients' prognosis and survival. The objectives of our study were to identify the magnitude of delayed diagnosis and its associated factors in women with breast cancer in...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/1471-2407-11-141

    authors: Norsa'adah B,Rampal KG,Rahmah MA,Naing NN,Biswal BM

    更新日期:2011-04-17 00:00:00

  • A ten-gene signature-based risk assessment model predicts the prognosis of lung adenocarcinoma.

    abstract:BACKGROUND:Lung adenocarcinoma (LUAD) is a major cause of cancer death. Therefore, identifying potential prognostic risk factors is critical to improve the survival of patients with LUAD. METHODS:Here, relevant datasets were downloaded from TCGA and GEO databases to screen the differentially expressed genes (DEGs). Un...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-020-07235-z

    authors: Jiang H,Xu S,Chen C

    更新日期:2020-08-20 00:00:00

  • Transcatheter arterial chemoembolization plus sorafenib versus transcatheter arterial chemoembolization alone to treat advanced hepatocellular carcinoma: a meta-analysis.

    abstract:BACKGROUND:Many studies have combined sorafenib with transcatheter arterial chemoembolization (TACE) to treat patients with advanced hepatocellular carcinoma (HCC), but the results are disputable. Thus, we conducted this meta-analysis to assess the efficacy and safety of the combination treatment in patients with advan...

    journal_title:BMC cancer

    pub_type: 杂志文章,meta分析

    doi:10.1186/s12885-017-3707-5

    authors: Cai R,Song R,Pang P,Yan Y,Liao Y,Zhou C,Wang S,Zhou X,Wang H,Zhang H,Sun H,Ma H

    更新日期:2017-11-06 00:00:00

  • Design of the study: how can health care help female breast cancer patients reduce their stress symptoms? A randomized intervention study with stepped-care.

    abstract:BACKGROUND:A life threatening illness such as breast cancer can lead to a secondary diagnosis of PTSD (post traumatic stress disorder) with intrusive thoughts and avoidance as major symptoms. In a former study by the research group, 80% of the patients with breast cancer reported a high level of stress symptoms close t...

    journal_title:BMC cancer

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1186/1471-2407-12-167

    authors: Nordin K,Rissanen R,Ahlgren J,Burell G,Fjällskog ML,Börjesson S,Arving C

    更新日期:2012-05-04 00:00:00

  • Androgen receptor and chemokine receptors 4 and 7 form a signaling axis to regulate CXCL12-dependent cellular motility.

    abstract:BACKGROUND:Identifying cellular signaling pathways that become corrupted in the presence of androgens that increase the metastatic potential of organ-confined tumor cells is critical to devising strategies capable of attenuating the metastatic progression of hormone-naïve, organ-confined tumors. In localized prostate c...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1201-5

    authors: Hsiao JJ,Ng BH,Smits MM,Wang J,Jasavala RJ,Martinez HD,Lee J,Alston JJ,Misonou H,Trimmer JS,Wright ME

    更新日期:2015-03-31 00:00:00

  • Small ubiquitin-related modifier 2/3 interacts with p65 and stabilizes it in the cytoplasm in HBV-associated hepatocellular carcinoma.

    abstract:BACKGROUND:SUMOylation, an important post-translational modification, associates with the development of hepatocellular carcinoma (HCC). p65, one of the most important subunits of NF-κB, is a key regulator in the development of HCC and has been reported to be SUMOylated by exogenous small ubiquitin-related modifier 3 (...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1665-3

    authors: Liu J,Sha M,Wang Q,Ma Y,Geng X,Gao Y,Feng L,Shen Y,Shen Y

    更新日期:2015-10-12 00:00:00

  • Total and partial cancer prevalence in the adult French population in 2008.

    abstract:BACKGROUND:To provide estimations of partial and total prevalence of 24 cancer sites in France in 2008. The estimations of partial prevalence were compared with the previous estimations for 2002. METHODS:Nationwide estimations of incidence and survival data from cancer registries were used for partial prevalence. Nati...

    journal_title:BMC cancer

    pub_type: 杂志文章

    doi:10.1186/s12885-015-1168-2

    authors: Colonna M,Mitton N,Bossard N,Belot A,Grosclaude P,French Network of Cancer Registries (FRANCIM).

    更新日期:2015-03-19 00:00:00

  • Clinical outcomes of HER2-positive metastatic breast cancer patients with brain metastasis treated with lapatinib and capecitabine: an open-label expanded access study in Korea.

    abstract:BACKGROUND:To evaluate efficacy in patients with brain metastasis (BM) on entry into the lapatinib expanded access program (LEAP). METHODS:LEAP is a worldwide, single-arm, open-label study. HER2-positive, locally-advanced or metastatic breast cancer patients with progression after an anthracycline, taxane, and trastuz...

    journal_title:BMC cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1186/1471-2407-12-322

    authors: Ro J,Park S,Kim S,Kim TY,Im YH,Rha SY,Chung JS,Moon H,Santillana S

    更新日期:2012-07-28 00:00:00